PMCH and obesity due to melanocortin 4 receptor deficiency: In this sense MCH, due to its actions on food intake, adiposity, energy expenditure, and food motivation, has attracted the attention of several pharmaceutical companies as a possible target for the development of anti-obesity drugs.